A Medicare molecular diagnostics program, administered by Palmetto GBA and adopted by several Medicare Administrative Contractors, that technically assesses molecular tests and assigns Z-codes for claims processing and local coverage.

Definition

The MolDx (Molecular Diagnostic Services) Program is a Medicare Administrative Contractor initiative, originally developed by Palmetto GBA and now used by multiple MACs including Noridian and CGS, that establishes coverage, coding, and pricing methodologies specific to molecular and genomic diagnostic tests billed to Medicare. Laboratories register their tests with MolDx and receive a unique test identifier known as a Z-code, which is required for claims submission and allows the program to track individual proprietary tests separately from generic CPT codes that would otherwise obscure which specific assay was performed. MolDx conducts a technical assessment (TA) of each registered test's analytical and clinical validity, and, where a Local Coverage Determination (LCD) exists for that test category, the technical assessment findings feed into whether Medicare will cover the test for its Medicare Administrative Contractor jurisdiction.

Why it matters

For molecular diagnostic and genomic test developers, MolDx registration and Z-code assignment is typically a prerequisite to reimbursement in MolDx-participating MAC jurisdictions, functioning alongside, and sometimes overlapping with, PAMA private payor rate reporting and FDA regulatory status. Because MolDx LCDs are jurisdiction-specific rather than a single national policy, a test's coverage status can differ across MAC jurisdictions until CMS or the MACs harmonize policy, which laboratories must track separately from FDA clearance or approval status.

Common pitfalls

•Assuming a Z-code alone guarantees Medicare payment; the code enables claims tracking, but coverage still depends on whether an applicable LCD covers the specific test and clinical indication.
•Treating MolDx technical assessment approval as equivalent to FDA clearance or approval; MolDx TA is a payor-driven evidentiary review distinct from FDA's premarket regulatory pathways.
•Overlooking that MolDx policies vary by MAC jurisdiction, so a test covered in one region may lack an active LCD, and therefore reimbursement certainty, in another.

Sources

CMS, Local Coverage Determination Process · CMS
Palmetto GBA MolDx Program · Palmetto GBA
CMS, CLFS & PAMA Reporting and Resources · CMS

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.